Researchers posit that GHRP-2 and GHRP-6 may activate the receptors by interacting with the enzyme phospholipase C (PLC), which cuts a specific membrane molecule (PIP) into two smaller signaling molecules called IP and DAG
When both pathways are activated together, the weight loss effects appear to be additive or even synergistic, which is why tirzepatide has demonstrated superior weight loss outcomes compared to semaglutide alone in head-to-head comparisons
PloS one , 16 (3), e0247307
However, no differences were observed in isometric torque production, specific torque, or histological measures of myofiber cross-sectional area or collagen deposition across any treatment group
Clinical evidence for glp-1 receptor agonists in aAzheimers disease: A systematic review
If you are non-diabetic, intake of semaglutide can cause a few temporary side effects